# Terumo Europe N.V. clinical trials: 25 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 25 trials with Terumo Europe N.V. as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Terumo Europe N.V.: 25 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/terumo-europe-n-v

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 25
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 25, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 22, 2026 | NCT07888738 | Evaluation of Safety, Performance and Usability of the TR Band DISTAL Device for Hemostasis Following Distal Radial Access in Coronary... | Terumo Europe N.V. | Observational | Not yet recruiting | Hemostasis, Distal Radial Artery Access (dTRA) | 320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888738) |
| June 22, 2023 | NCT05911633 | BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC) | Terumo Europe N.V. | Not applicable | Active not recruiting | Hepatocellular Carcinoma Non-resectable | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05911633) |
| January 31, 2023 | NCT05705973 | Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients | Terumo Europe N.V. | Observational | Active not recruiting | Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05705973) |
| July 11, 2022 | NCT05451862 | Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma. | Terumo Europe N.V. | Not applicable | Terminated | Hepatocellular Carcinoma | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05451862) |
| April 19, 2022 | NCT05335525 | Post-market Clinical Investigation of the Angio-Seal™ VIP VCD (ANGIO-SEAL CLOSE) | Terumo Europe N.V. | Observational | Unknown | Vascular Closure, Endovascular Procedure, Hemostasis, Peripheral Vascular Disease, Femoral Artery | 230 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05335525) |
| November 8, 2021 | NCT05111795 | Holmium-166 Retrospective Collection of Real-World Data | Terumo Europe N.V. | Observational | Completed | Hepatocellular Carcinoma, Metastatic Cancer | 146 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05111795) |
| August 30, 2021 | NCT05027698 | Post-Market Clinical Investigation of the FemoSeal™ VCS: A Prospective, Multi-Center Observational European Study | Terumo Europe N.V. | Observational | Completed | Vascular Closure, Endovascular Procedure, Hemostasis, Peripheral Vascular Disease | 230 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05027698) |
| September 14, 2020 | NCT04546477 | Prospective Multicenter Study to Confirm the Performance of the Renzan Stent in Treatment of SFA/POP Artery Disease | Terumo Europe N.V. | Not applicable | Completed | Superficial Femoral Artery Disease, Popliteal Artery Disease | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04546477) |
| January 18, 2020 | NCT04231929 | BioPearl™ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study. | Terumo Europe N.V. | Not applicable | Withdrawn | Hepatocellular Carcinoma | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04231929) |
| November 21, 2019 | NCT04171570 | DIStal Versus COnventional RADIAL Access for Coronary Angiography and Intervention | Terumo Europe N.V. | Not applicable | Completed | Coronary Disease | 1,309 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04171570) |
| June 20, 2018 | NCT03563274 | QuiremSpheres Observational Study | Terumo Europe N.V. | Observational | Terminated | Liver, Cancer of, Non-Resectable | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03563274) |
| April 20, 2018 | NCT03504228 | Prospective Single Arm CAS - ROADSAVER Study | Terumo Europe N.V. | Observational | Completed | Carotid Artery Stenosis | 1,967 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03504228) |
| February 15, 2017 | NCT03053596 | LifePearl Anthracyclin Registry in Selective Chemo-Embolization of Patients With Unresectable HCC (PARIS Registry) | Terumo Europe N.V. | Observational | Completed | Hepatocellular Carcinoma | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03053596) |
| October 20, 2016 | NCT02939924 | Treatment of Patients With Lesions in the Superficial Femoral and/ or Popliteal Arteries Using Kanshas Paclitaxel-coated Balloon Catheter. | Terumo Europe N.V. | Not applicable | Completed | Femoropopliteal Occlusive Disease, Peripheral Artery Disease | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02939924) |
| July 12, 2016 | NCT02828683 | Safety and Efficacy of TCD-10023 (Ultimaster) Drug-eluting Stent in STEMI Patients - MASTER Study | Terumo Europe N.V. | Not applicable | Completed | Acute ST Segment Elevation Myocardial Infarction | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02828683) |
| September 14, 2015 | NCT02548780 | LifePearl-Doxo Pharmacokinetic (PK) Study | Terumo Europe N.V. | Not applicable | Completed | HCC, Hepatocellular Carcinoma | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02548780) |
| September 11, 2015 | NCT02547480 | LifePearl-Iri Pharmacokinetic Study | Terumo Europe N.V. | Not applicable | Completed | Metastatic Colorectal Cancer, mCRC | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02547480) |
| November 20, 2014 | NCT02295683 | Renal Sympathetic Denervation by Iberis System in Patients With Uncontrolled Hypertension - Iberis-HTN Registry | Terumo Europe N.V. | Observational | Terminated | Resistant Hypertension | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02295683) |
| July 11, 2014 | NCT02188355 | Prospective, Single-arm, Multi Centre Observations Ultimaster Des Registry | Terumo Europe N.V. | Observational | Unknown | Coronary Artery Disease | 37,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02188355) |
| November 26, 2013 | NCT01994798 | Rapid Exchange Devices Observational Registry. | Terumo Europe N.V. | Observational | Unknown | Peripheral (Lowr Extremity) Arterial Disease. | 525 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01994798) |
| May 1, 2013 | NCT01844843 | Optical Frequency Domain Imaging (OFDI) Assessed Strut Coverage of New Terumo DES | Terumo Europe N.V. | Not applicable | Completed | Coronary Artery Disease | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01844843) |
| December 10, 2012 | NCT01745432 | Assessment of the Manageability and Safety of ADBLOCK Adhesion Barrier System in Laparoscopic Gynaecological Surgery | Terumo Europe N.V. | Phase 1 | Completed | UTERINE MYOMAS | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01745432) |
| January 6, 2011 | NCT01271361 | Randomized Study to Assess the Effect of ThRombus Aspiration on Flow Area in STEMI Patients | Terumo Europe N.V. | Phase 1/2 | Completed | Coronary Artery Disease, Myocardial Infarction, STEMI | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01271361) |
| December 16, 2010 | NCT01261273 | e-NOBORI Observational Registry of Nobori DES | Terumo Europe N.V. | Observational | Completed | Coronary Artery Disease | 18,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01261273) |
| October 30, 2009 | NCT01004575 | Safety and Efficacy Study of Kaname Coronary Stent System for the Treatment of Patients With Coronary Artery Disease | Terumo Europe N.V. | Not applicable | Completed | Coronary Artery Disease, Angioplasty, Transluminal, Percutaneous Coronary | 282 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01004575) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 1 |
| Phase 1/2 | 1 |
| Not applicable | 11 |
| Observational | 12 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 15 |
| Unknown | 3 |
| Terminated | 3 |
| Active not recruiting | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Hepatocellular | 6 |
| Coronary Artery Disease | 5 |
| ST Elevation Myocardial Infarction | 2 |
| Neoplasm Metastasis | 2 |
| Peripheral Vascular Diseases | 2 |
| Coronary Disease | 1 |
| Cardiovascular Diseases | 1 |
| Coronary Occlusion | 1 |
| Myocardial Ischemia | 1 |
| Myocardial Infarction | 1 |
| Peripheral Arterial Disease | 1 |
| Carotid Stenosis | 1 |
| Colorectal Neoplasms | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Burger restaurants in the United States](https://specstream.ai/data/businesses/burger-restaurants/united-states)
- [Generator installation repair companies in the United States](https://specstream.ai/data/businesses/generator-installation-repair-companies/united-states)
- [Paper mills in the United States](https://specstream.ai/data/businesses/paper-mills/united-states)
- [Ultrasound imaging clinics in the United States](https://specstream.ai/data/businesses/ultrasound-imaging-clinics/united-states)
- [Cheesesteak restaurants in the United States](https://specstream.ai/data/businesses/cheesesteak-restaurants/united-states)
- [Home builders in the United States](https://specstream.ai/data/businesses/home-builders/united-states)
